Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis

Objective: The autoimmune disease Multiple Sclerosis (MS) represents a heterogeneous disease pattern with an individual course that may lead to permanent disability. In addition to immuno-modulating therapies patients benefit from symptomatic approaches like intrathecal corticosteroid therapy (ICT),...

Full description

Bibliographic Details
Main Authors: Katja Vohl, Alexander Duscha, Barbara Gisevius, Johannes Kaisler, Ralf Gold, Aiden Haghikia
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Neurology
Subjects:
multiple sclerosis
disease progression
intrathecal corticosteroid therapy
clinical predictor
cerebrospinal fluid
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.00132/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2019.00132/full

Similar Items